Cargando…

Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers

PURPOSE: Vasomotor symptoms (VMS) such as hot flashes and night sweats are common in breast cancer patients and can affect both quality of life and treatment adherence. However, there is limited practical data to guide clinicians in the optimal selection of therapeutic strategies. A survey of health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cole, Katherine Marie, Clemons, Mark, Alzahrani, Meshari, Larocque, Gail, MacDonald, Fiona, Vandermeer, Lisa, Hutton, Brian, Piper, Ardelle, Pond, Greg, McGee, Sharon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219176/ https://www.ncbi.nlm.nih.gov/pubmed/34159473 http://dx.doi.org/10.1007/s10549-021-06186-8

Ejemplares similares

Vasomotor symptoms in early breast cancer—a “real world” exploration of the patient experience
por: Cole, Katherine Marie, et al.
Publicado: (2022)

Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
por: McGee, Sharon, et al.
Publicado: (2021)

Using machine learning to predict individual patient toxicities from cancer treatments
por: Cole, Katherine Marie, et al.
Publicado: (2022)

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation
por: McGee, Sharon, et al.
Publicado: (2021)

Delivery of cancer care via an outpatient telephone support line: a cross-sectional study of oncology nursing perspectives on quality and challenges
por: Shah, Hely, et al.
Publicado: (2022)

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
por: Clemons, Mark, et al.
Publicado: (2021)

The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer
por: Surujballi, Julian, et al.
Publicado: (2021)

Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey
por: Alzahrani, Mashari, et al.
Publicado: (2021)

P291 Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers
por: Beltran-Bless, A.-A., et al.
Publicado: (2023)

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events
por: Addison, Christina L., et al.
Publicado: (2014)

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey
por: AlZahrani, Mashari, et al.
Publicado: (2020)

Regularly scheduled physical examinations and the detection of breast cancer recurrences
por: Beltran-Bless, Ana-Alicia, et al.
Publicado: (2023)

A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer
por: Dent, Susan, et al.
Publicado: (2021)

Can routinely collected administrative data effectively be used to evaluate and validate endpoints used in breast cancer clinical trials? Protocol for a scoping review of the literature
por: Shah, Hely, et al.
Publicado: (2023)

Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey
por: Savard, Marie-France, et al.
Publicado: (2021)

The Rethinking Clinical Trials (REaCT) Program. A Canadian-Led Pragmatic Trials Program: Strategies for Integrating Knowledge Users into Trial Design
por: Saunders, Deanna, et al.
Publicado: (2021)

A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer
por: Fernandes, Ricardo, et al.
Publicado: (2023)

Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey
por: Alzahrani, Mashari, et al.
Publicado: (2021)

A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting
por: Clemons, M., et al.
Publicado: (2020)

Pharmacotherapy in patients with vasomotor disorders
por: Boerhout, C.K.M., et al.
Publicado: (2023)

Efficacy and safety of BNT162b2 vaccination in patients with solid cancer receiving anticancer therapy – a single centre prospective study
por: Shmueli, Einat S., et al.
Publicado: (2021)

P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?
por: Beltran-Bless, A.-A., et al.
Publicado: (2023)

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer
por: Hilton, J.F., et al.
Publicado: (2017)

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage breast cancer
por: Awan, Arif, et al.
Publicado: (2020)

Vasomotor Tumentia
por: Goodall, Alexander
Publicado: (1928)

Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program
por: Alshamsan, Bader, et al.
Publicado: (2022)

Autonomic correlations with MRI are abnormal in the brainstem vasomotor centre in Chronic Fatigue Syndrome
por: Barnden, Leighton R., et al.
Publicado: (2016)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Evolving Role of Risk Tailored Therapy in Early Stage HER2-Positive Breast Cancer: A Canadian Perspective
por: McGee, Sharon F., et al.
Publicado: (2022)

Epidemiology of Vasomotor Rhinitis
por: Settipane, Russell A
Publicado: (2009)

Histamine for Vasomotor Rhinitis
Publicado: (1944)

Migraine and the Vasomotor Theory
por: Handford, Henry
Publicado: (1898)

The Vasomotor System of the Pulp
por: Talbot, Eugene S.
Publicado: (1904)

Incidence, consequences and treatment of bone metastases in breast cancer patients—Experience from a single cancer centre
por: Kuchuk, I., et al.
Publicado: (2013)

The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression
por: Bryant, Richard J., et al.
Publicado: (2020)

Exploring patients’ experience and perception of being diagnosed with bladder cancer: a mixed‐methods approach
por: Tan, Wei Shen, et al.
Publicado: (2020)

Doxycycline-Induced Changes in Circulating MMP or TIMP2 Levels Are Not Associated with Skeletal-Related Event-Free or Overall Survival in Patients with Bone Metastases from Breast Cancer
por: Zhao, Huijun, et al.
Publicado: (2023)

Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?
por: Beltran-Bless, Ana-Alicia, et al.
Publicado: (2021)

The Vasomotor System in Anoxia and Asphyxia
por: Lindskog, G. E.
Publicado: (1939)

Characteristics of Nonallergic Vasomotor Rhinitis
por: Bernstein, Jonathan A
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2hr26h3hguagt2vjg7vjt445sq